Peritoneal Malignancies

Folder Peritoneal Malignancies

Documents

document Peritoneal Malignancies and Colorectal Peritoneal Metastases (Chapter 28, European Manual of Medicine: Coloproctology Second Edition)

By In Peritoneal Malignancies

The majority of patients with pseudomyxoma peritonei of appendiceal origin who have complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are cured. There is increasing evidence to support that similar principles of surgery and intraperitoneal chemotherapy can be effective in patients with peritoneal mesothelioma and colorectal peritoneal metastases. The key to a successful outcome is complete cytoreduction. This chapter discusses the evidence behind cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, mainly in colorectal peritoneal metastases, and the challenges associated in selecting patients in whom this strategy is appropriate.

video The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: a multicenter, randomized controlled trial

By In Peritoneal Malignancies

KSCP Visiting Fellow Free Paper - Eun Jung Park at ESCP Berlin 2017

video What's new in immuno- and chemotherapy for colorectal tumours? Prophylactic HIPEC in high-risk colonic cancer patients

By In Peritoneal Malignancies

Symposium - Diane Goere (France) at ESCP Nice 2018

video Colorectal Cancer: Cytoreduction with or without HIPEC for peritoneal carcinomatosis

By In Peritoneal Malignancies

Symposium - Diane Goere (France) at ESCP Virtually Vilnius 2020

video Improving Outcome in Colon Cancer: HIPEC for CRC: boom or bust and what about prophylactic

By In Peritoneal Malignancies

Scientific session - Delia Cortes Guiral (Spain) at ESCP Dublin 2022

ESCP Affiliates